COVID-19 UPDATE

Contact

BDSI remains committed to the chronic pain community during the COVID-19 pandemic. For more
information on access to our products, please call our customer service line at 1-800-469-0261.

Events & Presentations

Past Events

BDSI First Quarter 2021 Financial Results Call and Webcast

May 6, 2021 at 8:30 AM EDT

Listen to webcast

Supporting Materials

View Presentation 622.2 KB

March Investor Presentation

Mar 15, 2021

Supporting Materials

View Presentation 1.1 MB

BDSI Fourth Quarter 2020 Financial Results Call and Webcast

Mar 10, 2021 at 8:30 AM EST

Listen to webcast

Supporting Materials

View Presentation 751.1 KB

Piper Sandler 32nd Annual Healthcare Conference

Nov 23, 2020

Southwest IDEAS Investor Conference

Nov 18, 2020 at 8:00 AM EST

Listen to webcast

BDSI Third Quarter 2020 Financial Results Call and Webcast

Nov 5, 2020 at 8:30 AM EST

Listen to webcast

Supporting Materials

View Presentation 601.9 KB

Cantor Fitzgerald Global Healthcare Conference

Sep 17, 2020 at 11:20 AM EDT

Listen to webcast

H.C. Wainwright 22nd Annual Global Investor Conference

Sep 14, 2020 at 12:30 PM EDT

Listen to webcast

BDSI Second Quarter 2020 Financial Results Call and Webcast

Aug 5, 2020 at 8:30 AM EDT

Listen to webcast

Supporting Materials

View Presentation 662.8 KB

Recent BDSI News

BioDelivery Sciences Reports First Quarter 2021 Results May 6, 2021

Total Company Net Revenue of $41 Million , an Increase of 7% versus Prior Year Net Income of $5.2 Million , EBITDA Margin of 22% and Operating Cash Generation of $11 Million Conference Call and Webcast Scheduled for 8:30 AM EST Today RALEIGH, N.C. , May 06, 2021 (GLOBE NEWSWIRE) -- BioDelivery ...

BioDelivery Sciences to Report First Quarter 2021 Financial Results on May 6, 2021 April 20, 2021

RALEIGH, N.C. , April 20, 2021 (GLOBE NEWSWIRE) -- BioDelivery Sciences International, Inc. (NASDAQ: BDSI), a rapidly growing specialty pharmaceutical company dedicated to patients living with serious and complex chronic conditions, today announced that it will report its first quarter 2021 ...

BioDelivery Sciences Reports Strong Q4 and Record Full-Year 2020 Results March 10, 2021

Total Company Net Revenue Increased 40% versus Prior Year to Reach an All-Time High of $156.5 Million Record Level Profitability with Net Income of $25.7 Million , Full-Year EBITDA Margin of 26% and Operating Cash Generation of $25 Million Conference Call and Webcast Scheduled for 8:30 AM EST Today ...

More news

More events

Stay Connected

Stay up to date on the latest news

Get started now